Read More

ICER report rebukes Lykos’ MDMA-AP study

The Institute for Clinical and Economic Review (ICER) recently posted its revised evidence report assessing the comparative clinical effectiveness and value of 3,4-Methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP, a psychotherapy protocol from Lykos Therapeutics) for the treatment of post-traumatic stress disorder (PTSD). ICER provides independent evaluations of medical tests, treatments, and systems. The …